Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
A. Digiacomo
Observed name:
Antonio Digiacomo
Institution:
University of Ragusa
Observed institutions:
Hôpital Beaujon,
University of Ragusa,
Ospedale Regina Margherita,
Université Paris Diderot,
University of Palermo
OpenAlex ID:
A5089478711
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents
2018
·
Vincenza Calvaruso
, Giuseppe Cabibbo
, et al.
·
Gastroenterology
·
376
Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? The REAL Experience
2019
·
Vincenza Calvaruso
, Irene Cacciola
, et al.
·
The American Journal of Gastroenterology
·
47
Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST‐HCV cohort
2021
·
Vincenza Calvaruso
, Salvatore Petta
, et al.
·
Journal of Viral Hepatitis
·
25
PDF
Disease outcomes after DAA-induced SVR: Data from the resist-HCV cohort
2018
·
V. Calvaruso
, S. Petta
, et al.
·
Digestive and Liver Disease
·
7
Early occurrence of hepatocellular carcinoma (HCC) in patients with HCV cirrhosis treated with direct-acting antivirals (DAAs)
2017
·
V. Calvaruso
, G. Cabibbo
, et al.
·
Digestive and Liver Disease
·
5
Impact of age on viral kinetics of peginterferon alfa‐2a/ribavirin in chronic hepatitis C: final analysis from the PROPHESYS cohort
2013
·
A. Aronsohn
, I. Ancuta
, et al.
·
Journal of Viral Hepatitis
·
5
Occurrence of hepatocellular carcinoma in patients with hepatitis C virus related liver disease treated with direct-acting antivirals
2017
·
V. Calvaruso
, G. Cabibbo
, et al.
·
Journal of Hepatology
·
4
Risk of hepatocellular carcinoma (HCC) recurrence in HCV cirrhotic patients treated with Direct Acting Antivirals (DAAs)
2017
·
G. Cabibbo
, I. Cacciola
, et al.
·
Digestive and Liver Disease
·
3
Efficacy of oral direct acting antivirals for treatment of advanced chronic hepatitis or compensated cirrhosis due to hepatitis C virus infection: The real-life experience of the Sicily registry
2017
·
I. Cacciola
, S. Petta
, et al.
·
Digestive and Liver Disease
·
2
[Quantitative imaging in nephrology: limits and potentials of elastosonography].
2022
·
Antonio Granata
, Giulio Distefano
, et al.
·
PubMed
·
1
PDF
Pc.01.10 Liver and Cardiovascular Mortality After Daas: Data From the Resist-hcv Cohort
2019
·
B. Magro
, V. Calvaruso
, et al.
·
Digestive and Liver Disease
·
1
Treatment of 320 genotype 3 cirrhotic patients with 12 weeks Sofosbuvir/Velpatasvir with or without ribavirin: real life experience from Italy
2019
·
L. Pasulo
, M. Gambato
, et al.
·
Digestive and Liver Disease
·
1
Efficacy and safety of 12-week DAA regimens in HCV genotype 1b patients with compensated cirrhosis: data of RESIST-HCV Cohort
2017
·
S. Madonia
, V. Calvaruso
, et al.
·
Journal of Hepatology
·
1
Second-generation DAAs for HCV: real-life efficacy in the resist-HCV cohort
2020
·
Irene Cacciola
, Salvatore Petta
, et al.
·
Journal of Hepatology
Second-generation DAAs for HCV: real-life efficacy in the RESIST-HCV cohort
2019
·
I. Cacciola
, S. Petta
, et al.
·
Digestive and Liver Disease
The prevalence of liver diseases due Hepatitis C Virus (HCV) in Sicily: A population-based survey
2017
·
F. Cartabellotta
, V. Calvaruso
, et al.
·
Digestive and Liver Disease
Non-invasive tools to ruling out large varices: RESIST-HCV vs Baveno VI criteria in a large cohort of patients with HCV cirrhosis
2017
·
V. Calvaruso
, I. Cacciola
, et al.
·
Digestive and Liver Disease
Risk of hepatocellular carcinoma recurrence in hepatitis C cirrhotic patients treated with direct acting antivirals
2017
·
G. Cabibbo
, I. Cacciola
, et al.
·
Journal of Hepatology
Efficacy of oral Direct Acting Antivirals for the treatment of chronic hepatitis/cirhhosis due to hepatitis C virus infection: the real-life experience of the Sicily Registry
2017
·
I. Cacciola
, S. Petta
, et al.
·
Journal of Hepatology
Treatment of elderly HCV patients with severe fibrosis: safety and efficacy data from RESIST-HCV, a large regional database
2016
·
V. Di Marco
, G. Squadrito
, et al.
·
Digestive and Liver Disease
271 EFFICACY AND SAFETY OF PERCUTANEOUS MICROWAVE ABLATION FOR HCC > 3 cm. A SINGLE-CENTER EXPERIENCE
2013
·
M. Russello
, R. Benigno
, et al.
·
Journal of Hepatology
PDF
Show more works
View as search
Works count:
22
Citation count:
854
H-index:
5
I10-index:
4
Year
Topic
Type